| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 2.12e-05 | 5 | 259 | 3 | GO:0030156 | |
| GeneOntologyBiologicalProcess | intracellular sphingolipid homeostasis | 3.57e-07 | 6 | 259 | 4 | GO:0090156 | |
| GeneOntologyBiologicalProcess | negative regulation of sphingolipid biosynthetic process | 8.25e-07 | 7 | 259 | 4 | GO:0090155 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | CCP110 ABCA2 TRAF3IP1 MAP1B NUMBL HJURP SAXO1 NCLN SACS EHMT2 METTL18 COBL SEMA4A PLXNB3 MPP7 FLNA TBC1D15 CARMIL1 VPS4B RICTOR C10orf90 ATP13A2 SHQ1 ORMDL1 ORMDL3 ORMDL2 NEURL1 SNX18 CNTNAP2 MED25 LIMCH1 RIMS1 CNOT1 | 1.62e-05 | 1189 | 259 | 33 | GO:0044087 |
| GeneOntologyBiologicalProcess | negative regulation of ceramide biosynthetic process | 1.92e-05 | 5 | 259 | 3 | GO:1900060 | |
| GeneOntologyBiologicalProcess | regulation of sphingolipid biosynthetic process | 3.93e-05 | 16 | 259 | 4 | GO:0090153 | |
| GeneOntologyCellularComponent | cell-cell junction | MAGI1 XIRP1 SIPA1L3 MPDZ PTK7 FNDC1 FAT2 AJM1 NHS MPP7 MPP3 JCAD FLNA SYNM CNTNAP1 SHROOM2 CD2 CNTNAP2 PRKCG SCRIB CDH1 | 1.74e-05 | 591 | 260 | 21 | GO:0005911 |
| GeneOntologyCellularComponent | adherens junction | MAGI1 XIRP1 FAT2 AJM1 MPP7 MPP3 JCAD SYNM SHROOM2 SCRIB CDH1 | 7.40e-05 | 212 | 260 | 11 | GO:0005912 |
| GeneOntologyCellularComponent | anchoring junction | MAGI1 XIRP1 SIPA1L3 RPS8 MPDZ THSD1 PEAK3 PTK7 FNDC1 FAT2 AJM1 NHS MPP7 MPP3 JCAD FLNA FLNC SYNM CNTNAP1 SHROOM2 CD2 CNTNAP2 PRKCG SCRIB CDH1 EPB41L2 USP33 | 9.11e-05 | 976 | 260 | 27 | GO:0070161 |
| GeneOntologyCellularComponent | serine palmitoyltransferase complex | 1.02e-04 | 8 | 260 | 3 | GO:0017059 | |
| GeneOntologyCellularComponent | palmitoyltransferase complex | 2.91e-04 | 11 | 260 | 3 | GO:0002178 | |
| Domain | ORMDL | 2.61e-06 | 3 | 258 | 3 | IPR007203 | |
| Domain | ORMDL | 2.61e-06 | 3 | 258 | 3 | PF04061 | |
| Domain | IG_FLMN | 7.00e-06 | 10 | 258 | 4 | SM00557 | |
| Domain | Filamin | 1.09e-05 | 11 | 258 | 4 | PF00630 | |
| Domain | FILAMIN_REPEAT | 1.09e-05 | 11 | 258 | 4 | PS50194 | |
| Domain | Filamin/ABP280_repeat-like | 1.09e-05 | 11 | 258 | 4 | IPR017868 | |
| Domain | Filamin/ABP280_rpt | 1.09e-05 | 11 | 258 | 4 | IPR001298 | |
| Domain | PDZ | MAGI1 SIPA1L3 MPDZ MPP7 MPP3 ARHGEF12 SHROOM2 RIMS1 SCRIB AHNAK2 | 2.69e-05 | 141 | 258 | 10 | PF00595 |
| Domain | PDZ | MAGI1 SIPA1L3 MPDZ MPP7 MPP3 ARHGEF12 SHROOM2 RIMS1 SCRIB AHNAK2 | 4.08e-05 | 148 | 258 | 10 | SM00228 |
| Domain | - | MAGI1 SIPA1L3 MPDZ MPP7 MPP3 ARHGEF12 SHROOM2 RIMS1 SCRIB AHNAK2 | 4.57e-05 | 150 | 258 | 10 | 2.30.42.10 |
| Domain | PDZ | MAGI1 SIPA1L3 MPDZ MPP7 MPP3 ARHGEF12 SHROOM2 RIMS1 SCRIB AHNAK2 | 4.84e-05 | 151 | 258 | 10 | PS50106 |
| Domain | PDZ | MAGI1 SIPA1L3 MPDZ MPP7 MPP3 ARHGEF12 SHROOM2 RIMS1 SCRIB AHNAK2 | 5.11e-05 | 152 | 258 | 10 | IPR001478 |
| Domain | FA58C_3 | 1.77e-04 | 21 | 258 | 4 | PS50022 | |
| Domain | FA58C | 1.77e-04 | 21 | 258 | 4 | SM00231 | |
| Domain | FA58C_1 | 1.77e-04 | 21 | 258 | 4 | PS01285 | |
| Domain | FA58C_2 | 1.77e-04 | 21 | 258 | 4 | PS01286 | |
| Domain | SH3_2 | 1.88e-04 | 86 | 258 | 7 | PF07653 | |
| Domain | SH3_2 | 1.88e-04 | 86 | 258 | 7 | IPR011511 | |
| Domain | FAM181 | 1.90e-04 | 2 | 258 | 2 | IPR029359 | |
| Domain | FAM181 | 1.90e-04 | 2 | 258 | 2 | PF15238 | |
| Domain | CH | 2.74e-04 | 65 | 258 | 6 | SM00033 | |
| Domain | F5_F8_type_C | 3.04e-04 | 24 | 258 | 4 | PF00754 | |
| Domain | FA58C | 3.04e-04 | 24 | 258 | 4 | IPR000421 | |
| Domain | Ig-like_fold | POGLUT3 TRIO CD83 PTK7 FNDC1 PTPRZ1 CRLF3 RIMBP3C SEMA4A KIR2DS5 PLXNB1 PLXNB3 NDNF FLNA FLNC TRIM3 RIMBP3 CD2 IGHM TREM1 RIMBP3B FCAMR | 3.38e-04 | 706 | 258 | 22 | IPR013783 |
| Domain | CH | 4.10e-04 | 70 | 258 | 6 | PF00307 | |
| Domain | - | 4.43e-04 | 71 | 258 | 6 | 1.10.418.10 | |
| Domain | CH | 5.15e-04 | 73 | 258 | 6 | PS50021 | |
| Domain | CH-domain | 5.95e-04 | 75 | 258 | 6 | IPR001715 | |
| Domain | L27 | 6.73e-04 | 13 | 258 | 3 | SM00569 | |
| Domain | L27 | 6.73e-04 | 13 | 258 | 3 | PS51022 | |
| Domain | L27_dom | 6.73e-04 | 13 | 258 | 3 | IPR004172 | |
| Domain | Plexin_repeat | 9.44e-04 | 32 | 258 | 4 | IPR002165 | |
| Domain | PSI | 9.44e-04 | 32 | 258 | 4 | PF01437 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MAGI1 CCP110 HIVEP1 MAP1B TRIO NUMBL EXPH5 SEC24A SIPA1L3 HJURP MAP3K20 MPDZ IRS1 SYNJ2 COBL NHS KIF2A HECTD1 JCAD CARMIL1 APBB1 RICTOR ALS2 CBX4 CDC14A DENND4C E2F8 C2CD3 NEURL1 PRKCG LIMCH1 SCRIB AQR EPB41L2 AHNAK2 | 8.38e-16 | 861 | 265 | 35 | 36931259 |
| Pubmed | MAP1B TRIO NUMBL SIPA1L3 RPS8 SACS WASHC5 PTPRZ1 AJM1 KIF2A METAP2 VARS1 WNK2 GPI FLNA FLNC SFPQ CARMIL1 CNTNAP1 ARHGEF12 KIAA1549 UPF1 IDH2 SHROOM2 TRIM3 LRCH3 GUCY1A2 TKT IGHM TMPO PRKCG LIMCH1 RIMS1 SCRIB CNOT1 EPB41L2 | 3.59e-10 | 1431 | 265 | 36 | 37142655 | |
| Pubmed | MAGI1 NCOA3 TRAF3IP1 TRIO NUMBL SIPA1L3 MPDZ EHMT2 KIF2A MGA KCNT1 WNK2 SFPQ CNTNAP1 NSD1 ARHGEF12 UPF1 TRIM3 NCOR2 PRKCG LIMCH1 RIMS1 SCRIB CABIN1 CNOT1 EPB41L2 PHACTR1 | 7.35e-09 | 963 | 265 | 27 | 28671696 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ABCA2 KMT2B TRIO SIPA1L3 SREBF1 IRS1 NCLN TRRAP ELAC2 TMCC2 MCM3AP COBL HECTD1 WNK2 MPP3 FLNA FLNC BICRA NSD1 ATP13A2 CCDC142 NCOR2 C2CD3 CTDP1 HMGXB3 DEPDC5 STK40 CABIN1 AHNAK2 | 8.52e-09 | 1105 | 265 | 29 | 35748872 |
| Pubmed | HJURP RIPPLY3 ITGA9 ZFYVE1 SIAE KIF2A MTO1 MGA PLXNB1 FLNA SFPQ NSD1 RICTOR ALS2 SHROOM2 ZNF496 E2F8 CCND2 NPHP3 PAXBP1 TBC1D31 SLC20A1 ATRNL1 GRAMD2B HMGXB3 CDH1 CNOT1 PHACTR1 | 2.19e-08 | 1084 | 265 | 28 | 11544199 | |
| Pubmed | MAGI1 MAP1B NUMBL SEC24A RPS8 MPDZ THSD1 ARHGAP29 MPP7 TBCE TBC1D15 CARMIL1 ATG2B ARHGEF12 RICTOR UPF1 DENND4C TMPO LRP6 SCRIB CNOT1 EPB41L2 | 3.27e-08 | 708 | 265 | 22 | 39231216 | |
| Pubmed | 3.63e-08 | 122 | 265 | 10 | 30773093 | ||
| Pubmed | MAP1B TRIO AASDHPPT NCLN PTK7 CACNG3 WASHC5 AJM1 TMCC2 KIF2A VARS1 WNK2 JCAD FLNA SFPQ U2SURP CNTNAP1 ATG2B APBB1 RICTOR IDH2 SHROOM2 CNTNAP2 PRKCG RIMS1 CNOT1 EPB41L2 PHACTR1 | 6.16e-08 | 1139 | 265 | 28 | 36417873 | |
| Pubmed | MAGI1 CCP110 SIPA1L3 MAP3K20 MPDZ LRCH1 CRLF3 KIF2A HECTD1 MPP7 JCAD KIAA1549 RICTOR DENND4C LRCH3 SNX18 CNOT1 | 7.24e-08 | 446 | 265 | 17 | 24255178 | |
| Pubmed | CCP110 TRIO SIPA1L3 MPDZ ARHGAP29 COBL NHS HECTD1 ATG2B ARHGEF12 DENND4C SCRIB | 8.32e-08 | 209 | 265 | 12 | 36779422 | |
| Pubmed | MAP1B WASHC5 MGA VARS1 FLNA FLNC ATG2B RICTOR UPF1 TMPO SCRIB EPB41L2 | 1.13e-07 | 215 | 265 | 12 | 35973513 | |
| Pubmed | METTL3 KMT2B GALNT3 NUMBL SIPA1L3 MAP3K20 MPDZ TMEM205 TRRAP NKRF MAN1A2 EHMT2 METTL18 KIF2A VARS1 MPP7 RCE1 REXO4 PARP2 NSD1 ARHGEF12 RICTOR CBX4 LRCH3 ORMDL1 PAXBP1 BAZ2A SLC25A10 MED25 LIMCH1 AQR EPB41L2 | 1.62e-07 | 1497 | 265 | 32 | 31527615 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | SIPA1L3 RPS8 KRBA1 MCM3AP ARHGAP29 MGA SYNM U2SURP NCOR2 C2CD3 ZNF69 | 1.93e-07 | 184 | 265 | 11 | 32908313 |
| Pubmed | KMT2B EHMT2 SYNJ2 MYO18B WNK2 FLNA FLNC AFF2 BICRA CNTNAP1 SHROOM2 BAZ2A TMPO RIMS1 | 2.82e-07 | 329 | 265 | 14 | 17474147 | |
| Pubmed | ORMDL proteins are a conserved new family of endoplasmic reticulum membrane proteins. | 4.37e-07 | 3 | 265 | 3 | 12093374 | |
| Pubmed | Mammalian ORMDL proteins mediate the feedback response in ceramide biosynthesis. | 4.37e-07 | 3 | 265 | 3 | 23066021 | |
| Pubmed | A reverse signaling pathway downstream of Sema4A controls cell migration via Scrib. | 4.37e-07 | 3 | 265 | 3 | 28007914 | |
| Pubmed | Simultaneous reduction of all ORMDL proteins decreases the threshold of mast cell activation. | 4.37e-07 | 3 | 265 | 3 | 37316542 | |
| Pubmed | 4.37e-07 | 3 | 265 | 3 | 25395622 | ||
| Pubmed | NCOA3 HIVEP1 KMT2B EHMT2 TAF1 MGA S100PBP FLNA TBC1D15 VPS4B ATG2B DENND4C NCOR2 TLE1 CNOT1 | 9.17e-07 | 418 | 265 | 15 | 34709266 | |
| Pubmed | MAGI1 HIVEP1 EXPH5 SYNJ2 MCM3AP COBL TAF1 MGA WNK2 FLNA FLNC SFPQ BICRA CBLB IRAG2 EPB41L2 | 1.22e-06 | 486 | 265 | 16 | 20936779 | |
| Pubmed | MAGI1 WWC3 SIPA1L3 RPS8 IRS1 ELAC2 NKRF AXIN2 NHS KIF2A MGA HECTD1 VARS1 GPI ANKRD35 FLNA TCF7 SFPQ VPS4B U2SURP UPF1 NCOR2 PAXBP1 TMPO LIMCH1 CDH1 AQR | 1.26e-06 | 1247 | 265 | 27 | 27684187 | |
| Pubmed | KMT2B MAP1B MPDZ TRRAP NKRF TAF1 MGA FLNA TBC1D15 ATG2B APBB1 NSD1 UPF1 BAZ2A TMPO SCRIB CNOT1 | 1.31e-06 | 549 | 265 | 17 | 38280479 | |
| Pubmed | CCDC125 TMEM126B SREBF1 TRRAP EHMT2 MCM3AP NHS THAP3 MTO1 MGA HECTD1 TBCE ASNSD1 GPI FLNA BICRA RICTOR C10orf90 SPACA9 UPF1 SNX14 TKT SLC20A1 TLE1 SLC25A10 DEPDC5 CNOT1 PADI3 | 1.31e-06 | 1327 | 265 | 28 | 32694731 | |
| Pubmed | POGLUT3 NUMBL TMEM126B RPS8 MRPL43 MPDZ NCLN ELAC2 CEMIP2 PTK7 NCBP3 SACS EHMT2 MPP7 TBC1D15 SYNM APBB1 KIAA1549 RICTOR UPF1 PAXBP1 TBC1D31 BAZ2A SLC20A1 TRABD TMPO SCRIB AQR EPB41L2 USP33 | 1.34e-06 | 1487 | 265 | 30 | 33957083 | |
| Pubmed | 1.40e-06 | 104 | 265 | 8 | 9205841 | ||
| Pubmed | Planar cell polarity defects and defective Vangl2 trafficking in mutants for the COPII gene Sec24b. | 1.55e-06 | 12 | 265 | 4 | 20215345 | |
| Pubmed | 1.74e-06 | 4 | 265 | 3 | 6188152 | ||
| Pubmed | RIM-BP3 is a manchette-associated protein essential for spermiogenesis. | 1.74e-06 | 4 | 265 | 3 | 19091768 | |
| Pubmed | 1.74e-06 | 4 | 265 | 3 | 31880535 | ||
| Pubmed | 1.74e-06 | 4 | 265 | 3 | 3569880 | ||
| Pubmed | 1.74e-06 | 4 | 265 | 3 | 20182505 | ||
| Pubmed | 1.74e-06 | 4 | 265 | 3 | 7565685 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | MAGI1 NUMBL SIPA1L3 CEMIP2 SYNJ2 ARHGAP29 NHS MPP7 JCAD FLNA CARMIL1 ARHGEF12 DENND4C TMPO LIMCH1 SCRIB CDH1 | 1.93e-06 | 565 | 265 | 17 | 25468996 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NCOA3 HIVEP1 KMT2B ESRRA PEPD TRRAP UNG FLNA CARMIL1 RICTOR NCOR2 PAXBP1 BAZ2A TKT CTDP1 TMPO LIMCH1 RIMS1 SCRIB EPB41L2 | 2.45e-06 | 774 | 265 | 20 | 15302935 |
| Pubmed | 4.32e-06 | 5 | 265 | 3 | 12183458 | ||
| Pubmed | Lyb-8.2: A new B cell antigen defined and characterized with a monoclonal antibody. | 4.32e-06 | 5 | 265 | 3 | 6984010 | |
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 4.32e-06 | 5 | 265 | 3 | 17855024 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | MAP1B RPS8 NCLN TRRAP F5 NKRF NCBP3 SACS KIF2A MGA VARS1 GPI FLNA FLNC TBC1D15 SFPQ U2SURP SLC20A1 TMPO SCRIB CNOT1 AQR EPB41L2 | 4.44e-06 | 1024 | 265 | 23 | 24711643 |
| Pubmed | TRIO LRCH1 CEMIP2 PTK7 COBL NHS MPP7 CARMIL1 RICTOR ERICH5 CBLB LRCH3 SCRIB EPB41L2 | 5.10e-06 | 421 | 265 | 14 | 36976175 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MAP1B RPS8 MAP3K20 TRRAP ELAC2 NKRF WASHC5 MCM3AP KIF2A MGA METAP2 VARS1 GPI FLNA FLNC REXO4 SFPQ U2SURP RICTOR UPF1 NCOR2 BAZ2A TKT SCRIB AQR EPB41L2 AHNAK2 | 5.71e-06 | 1353 | 265 | 27 | 29467282 |
| Pubmed | SREBF1 AASDHPPT TRRAP EHMT2 COBL MGA VAV2 MAP3K19 ASNSD1 JCAD FLNA FAT4 TBC1D15 SFPQ UPF1 NCOR2 TRABD IRAG2 LIMCH1 | 6.29e-06 | 754 | 265 | 19 | 35906200 | |
| Pubmed | EXPH5 SEC24A NHS SYNM APBB1 KIAA1549 TBC1D31 MEIOC SCRIB CNOT1 AHNAK2 | 6.36e-06 | 263 | 265 | 11 | 34702444 | |
| Pubmed | 6.56e-06 | 60 | 265 | 6 | 21555518 | ||
| Pubmed | TRIO NUMBL SEC24A SIPA1L3 CEMIP2 WASHC5 PTPRZ1 CRLF3 NHS UNG MPP7 JCAD KIAA1549 RICTOR PTPN18 CDC14A NCOR2 C2CD3 TBC1D31 TMPO LRP6 SCRIB CNOT1 | 6.56e-06 | 1049 | 265 | 23 | 27880917 | |
| Pubmed | A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition. | CYP2A6 FREM2 MCM3AP KIF2A FAM181B TBC1D15 CBX4 CBLB SEC31B SHQ1 BAZ2A TKT SLC20A1 ZNF804B | 6.66e-06 | 431 | 265 | 14 | 33660365 |
| Pubmed | CCP110 EXPH5 RC3H1 SIPA1L3 KRBA1 AHRR FAT2 SACS TMCC2 MGA HECTD1 SYNM RICTOR NPHP3 ATRNL1 | 6.83e-06 | 493 | 265 | 15 | 15368895 | |
| Pubmed | 7.45e-06 | 130 | 265 | 8 | 12421765 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | EXPH5 NCLN TRRAP NCBP3 KRBA1 COBL UNG KIF2A CARMIL1 U2SURP SNX14 SLC25A10 TMPO LIMCH1 CNOT1 | 7.52e-06 | 497 | 265 | 15 | 36774506 |
| Pubmed | 8.60e-06 | 6 | 265 | 3 | 25691431 | ||
| Pubmed | 8.60e-06 | 6 | 265 | 3 | 447675 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | MAGI1 NUMBL EXPH5 CEMIP2 PTK7 COBL PLXNB1 MPP7 CARMIL1 APBB1 KIAA1549 RICTOR ATP10D GRAMD2B SCRIB EPB41L2 | 9.04e-06 | 569 | 265 | 16 | 30639242 |
| Pubmed | 9.27e-06 | 18 | 265 | 4 | 20844743 | ||
| Pubmed | MAGI1 RC3H1 SIPA1L3 MPDZ NCBP3 COBL JCAD FLNA SFPQ UPF1 SCRIB | 9.36e-06 | 274 | 265 | 11 | 34244482 | |
| Pubmed | TRIO EML6 SACS SEMA4A FLNA NSD1 SPACA9 KCTD20 HMGXB3 SCRIB CNOT1 AHNAK2 | 1.06e-05 | 332 | 265 | 12 | 37433992 | |
| Pubmed | CCP110 METTL3 MAP1B F5 ELAC2 EHMT2 UNG PARP2 ATG2B CBX4 DENND4C C2CD3 TBC1D31 MED25 SCRIB CABIN1 CNOT1 | 1.10e-05 | 645 | 265 | 17 | 25281560 | |
| Pubmed | MAP1B SREBF1 MPDZ NCLN NKRF CEMIP2 PTK7 FREM2 WASHC5 KIF2A PLXNB1 RICTOR SLC25A10 SCRIB RUBCN AQR USP33 | 1.21e-05 | 650 | 265 | 17 | 38777146 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | METTL3 EXPH5 SIPA1L3 RPS8 MAP3K20 LRCH1 F5 NKRF KIF2A METAP2 FLNA REXO4 SFPQ SYNM DDX60 PARP2 UPF1 LRCH3 TKT KCTD20 TMPO SCRIB CDH1 AQR EPB41L2 | 1.36e-05 | 1257 | 265 | 25 | 36526897 |
| Pubmed | 1.50e-05 | 7 | 265 | 3 | 9630227 | ||
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | MAN2C1 MAP1B SEC24A TRRAP HECTD1 VARS1 GPI FLNA FLNC SFPQ UPF1 TKT | 1.51e-05 | 344 | 265 | 12 | 30333137 |
| Pubmed | ABCA2 ZFYVE1 LRCH1 CEMIP2 SYNJ2 WASHC5 KCNT1 WNK2 PLXNB1 CERK KIAA1549 CNTNAP2 HMGXB3 DEPDC5 CNOT1 | 1.57e-05 | 529 | 265 | 15 | 14621295 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ABCA2 GALNT3 MAP1B SREBF1 EXTL2 NCLN ELAC2 CEMIP2 PTK7 SIAE MAN1A2 KIF2A HECTD1 PLXNB1 RCE1 FAT4 CNTNAP1 KIAA1549 H6PD SNX14 TMPO LRP6 CERCAM SCRIB | 1.89e-05 | 1201 | 265 | 24 | 35696571 |
| Pubmed | TRAF1 HIVEP1 KMT2B NUMBL PEPD SREBF1 ARID5A SACS TAF1 WNK2 FAT4 APBB1 IGHM TMPO PRKCG EPB41L2 | 2.03e-05 | 608 | 265 | 16 | 16713569 | |
| Pubmed | 2.33e-05 | 152 | 265 | 8 | 38360978 | ||
| Pubmed | 2.60e-05 | 23 | 265 | 4 | 9225980 | ||
| Pubmed | 2.63e-05 | 46 | 265 | 5 | 30419336 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 2.71e-05 | 202 | 265 | 9 | 33005030 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | MAP1B NUMBL RPS8 LRCH1 TRRAP NKRF SACS KIF2A VARS1 PLXNB1 FLNC REXO4 SFPQ U2SURP CBX4 UPF1 IDH2 PAXBP1 SLC25A10 TMPO CNOT1 AQR | 3.29e-05 | 1082 | 265 | 22 | 38697112 |
| Pubmed | Hmga2 is required for canonical WNT signaling during lung development. | 3.67e-05 | 25 | 265 | 4 | 24661562 | |
| Pubmed | CCP110 NCOA3 METTL3 MAP3K20 PHLDA2 EHMT2 NHS FLNA TBC1D15 TROAP DENND4C CTDP1 SCRIB EPB41L2 | 3.68e-05 | 503 | 265 | 14 | 16964243 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | MAP1B NUMBL RPS8 PEPD AASDHPPT NKRF GPI FLNA SFPQ CARMIL1 U2SURP ATG2B APBB1 UPF1 BAZ2A TKT TMPO SCRIB EPB41L2 AHNAK2 | 3.71e-05 | 934 | 265 | 20 | 33916271 |
| Pubmed | Insights into the ubiquitin-proteasome system of human embryonic stem cells. | 4.57e-05 | 269 | 265 | 10 | 29511261 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MAP1B RC3H1 ESRRA ZFYVE1 SYNJ2 MGA METAP2 VARS1 FLNA FLNC REXO4 DDX60 UPF1 TKT SNX18 CNOT1 AHNAK2 | 4.70e-05 | 724 | 265 | 17 | 36232890 |
| Pubmed | MAP1B TRRAP NKRF MCM3AP HECTD1 FLNA FLNC REXO4 SFPQ U2SURP NSD1 UPF1 BAZ2A CNOT1 AQR EPB41L2 | 4.77e-05 | 653 | 265 | 16 | 22586326 | |
| Pubmed | 5.05e-05 | 10 | 265 | 3 | 19071123 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | POGLUT3 SEC24A RPS8 IRS1 NCLN ZFYVE1 PTK7 MAN1A2 AJM1 VARS1 ANKRD35 FLNA FLNC SFPQ U2SURP CNTNAP1 CBX4 IDH2 H6PD NCOR2 ORMDL3 TKT TLE1 SLC25A10 CERCAM EPB41L2 | 5.31e-05 | 1451 | 265 | 26 | 30550785 |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | CCP110 NCOA3 NUMBL SEC24A RPS8 MAP3K20 ZFYVE1 LRCH1 WASHC5 MCM3AP ARHGAP29 METAP2 TBC1D15 RICTOR UPF1 DENND4C SHQ1 SNX18 KCTD20 LIMCH1 CNOT1 | 5.35e-05 | 1038 | 265 | 21 | 26673895 |
| Pubmed | ABCA2 TRAF3IP1 TRIO SIPA1L3 RIPPLY3 MAN1A2 SACS EHMT2 TAF1 HECTD1 METAP2 VARS1 PLXNB3 JCAD SYNM CNTNAP1 APBB1 SEC31B SHROOM2 ATRNL1 CERCAM SCRIB CABIN1 USP33 | 5.51e-05 | 1285 | 265 | 24 | 35914814 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | RPS8 HJURP SREBF1 IRS1 NCLN LRCH1 TMEM205 CEMIP2 PTK7 MAN1A2 WASHC5 MGA GPI FLNA FLNC TBC1D15 SFPQ CNTNAP1 CBX4 NCOR2 TMPO CNOT1 AQR | 5.57e-05 | 1203 | 265 | 23 | 29180619 |
| Pubmed | Semaphorin4A promotes lung cancer by activation of NF-κB pathway mediated by PlexinB1. | 5.78e-05 | 2 | 265 | 2 | 37901456 | |
| Pubmed | 5.78e-05 | 2 | 265 | 2 | 30876690 | ||
| Pubmed | Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors. | 5.78e-05 | 2 | 265 | 2 | 17721511 | |
| Pubmed | Loss of FilaminC (FLNc) results in severe defects in myogenesis and myotube structure. | 5.78e-05 | 2 | 265 | 2 | 16914736 | |
| Pubmed | 5.78e-05 | 2 | 265 | 2 | 1302041 | ||
| Pubmed | 5.78e-05 | 2 | 265 | 2 | 15169884 | ||
| Pubmed | 5.78e-05 | 2 | 265 | 2 | 36661138 | ||
| Pubmed | 5.78e-05 | 2 | 265 | 2 | 28356423 | ||
| Pubmed | 5.78e-05 | 2 | 265 | 2 | 1520280 | ||
| Pubmed | 5.78e-05 | 2 | 265 | 2 | 23917075 | ||
| Pubmed | Obligatory roles of filamin A in E-cadherin-mediated cell-cell adhesion in epidermal keratinocytes. | 5.78e-05 | 2 | 265 | 2 | 24120284 | |
| Pubmed | Circadian Regulation of Hepatic Cytochrome P450 2a5 by Peroxisome Proliferator-Activated Receptor γ. | 5.78e-05 | 2 | 265 | 2 | 30154104 | |
| Pubmed | ORMDL proteins regulate ceramide levels during sterile inflammation. | 5.78e-05 | 2 | 265 | 2 | 27313060 | |
| Pubmed | 5.78e-05 | 2 | 265 | 2 | 27545877 | ||
| Pubmed | 5.78e-05 | 2 | 265 | 2 | 21418183 | ||
| Pubmed | 5.78e-05 | 2 | 265 | 2 | 22700965 | ||
| Pubmed | 5.78e-05 | 2 | 265 | 2 | 16344308 | ||
| Pubmed | METTL3 Promotes Osteosarcoma Metastasis via an m6A-dependent Epigenetic Activity of CBX4. | 5.78e-05 | 2 | 265 | 2 | 38538251 | |
| Pubmed | 5.78e-05 | 2 | 265 | 2 | 10679933 | ||
| Pubmed | 5.78e-05 | 2 | 265 | 2 | 21972110 | ||
| Pubmed | A novel structural unit in the N-terminal region of filamins. | 5.78e-05 | 2 | 265 | 2 | 24469451 | |
| Interaction | YWHAH interactions | CCDC125 MAGI1 CCP110 NCOA3 ABCA2 HIVEP1 TRIO NUMBL EXPH5 SEC24A SIPA1L3 HJURP MAP3K20 MPDZ IRS1 SYNJ2 SRSF8 COBL NHS KIF2A HECTD1 WNK2 JCAD CARMIL1 APBB1 RICTOR ALS2 CBX4 CDC14A DENND4C E2F8 C2CD3 LIMCH1 RIMS1 SCRIB RUBCN AQR EPB41L2 AHNAK2 | 8.68e-09 | 1102 | 259 | 39 | int:YWHAH |
| Interaction | YWHAG interactions | MAGI1 CCP110 HIVEP1 NUMBL EXPH5 SEC24A RC3H1 SIPA1L3 HJURP MAP3K20 MPDZ IRS1 TRRAP SYNJ2 SRSF8 OSBPL7 ARHGAP29 COBL NHS KIF2A HECTD1 JCAD FLNA CARMIL1 APBB1 RICTOR ALS2 CBX4 SHROOM2 CDC14A DENND4C E2F8 LRCH3 C2CD3 PRKCG SCRIB RUBCN AQR EPB41L2 AHNAK2 | 8.21e-08 | 1248 | 259 | 40 | int:YWHAG |
| Interaction | SFN interactions | CCDC125 MAGI1 CCP110 MAP1B EXPH5 SIPA1L3 RPS8 MAP3K20 IRS1 SYNJ2 SRSF8 COBL NHS KIF2A HECTD1 JCAD SFPQ CARMIL1 RICTOR CBX4 TEX14 DENND4C TKT SCRIB CDH1 EPB41L2 AHNAK2 | 3.17e-07 | 692 | 259 | 27 | int:SFN |
| Interaction | YWHAE interactions | CCDC125 HIVEP1 MAP1B NUMBL EXPH5 SEC24A RC3H1 SIPA1L3 RPS8 HJURP MAP3K20 IRS1 LRCH1 SYNJ2 NHS MGA HECTD1 METAP2 WNK2 JCAD FLNA SFPQ RICTOR ALS2 CBX4 SHROOM2 CDC14A DENND4C E2F8 LRCH3 NCOR2 IRAG2 TMPO PRKCG DEPDC5 CDH1 RUBCN EPB41L2 | 7.59e-07 | 1256 | 259 | 38 | int:YWHAE |
| Interaction | VASP interactions | MAGI1 CCP110 XIRP1 NUMBL SEC24A SIPA1L3 MRPL43 MPDZ SYNJ2 NHS APBB1 ARHGEF12 RICTOR LIMCH1 CDH1 | 6.68e-06 | 294 | 259 | 15 | int:VASP |
| Interaction | GSK3B interactions | CCP110 NCOA3 MAP1B TRIO SIPA1L3 SREBF1 MPDZ IRS1 AXIN2 KRBA1 ARHGAP29 COBL NHS HECTD1 GPI FLNA SFPQ ATG2B ARHGEF12 RICTOR C10orf90 DENND4C TLE1 IGHM TMPO LRP6 SCRIB CDH1 | 7.69e-06 | 868 | 259 | 28 | int:GSK3B |
| Interaction | GSK3A interactions | CCP110 TRIO SIPA1L3 RPS8 MPDZ AXIN2 KRBA1 ARHGAP29 COBL NHS HECTD1 U2SURP ATG2B ARHGEF12 RICTOR DENND4C LRP6 PRKCG SCRIB | 9.76e-06 | 464 | 259 | 19 | int:GSK3A |
| Interaction | LIN7A interactions | 1.03e-05 | 59 | 259 | 7 | int:LIN7A | |
| Interaction | ITGB3 interactions | MAN2C1 MAP1B SEC24A TRRAP PTPRZ1 HECTD1 VARS1 FLNA FLNC SFPQ UPF1 | 1.30e-05 | 170 | 259 | 11 | int:ITGB3 |
| Interaction | KCNA3 interactions | MAGI1 MAP1B NUMBL EXPH5 SEC24A RPS8 MPDZ THSD1 KCNC4 ARHGAP29 COBL MPP7 TBCE TBC1D15 AFF2 CARMIL1 ATG2B ARHGEF12 RICTOR UPF1 DENND4C TMPO LRP6 RIMS1 SCRIB CNOT1 EPB41L2 | 2.28e-05 | 871 | 259 | 27 | int:KCNA3 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q34 | 1.35e-04 | 325 | 267 | 9 | chr9q34 | |
| Cytoband | 1p21 | 3.60e-04 | 24 | 267 | 3 | 1p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q22 | 4.20e-04 | 107 | 267 | 5 | chr11q22 | |
| GeneFamily | PDZ domain containing | MAGI1 SIPA1L3 MPDZ MPP7 MPP3 ARHGEF12 SHROOM2 RIMS1 SCRIB AHNAK2 | 1.50e-06 | 152 | 167 | 10 | 1220 |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 7.63e-05 | 25 | 167 | 4 | 775 | |
| GeneFamily | Peptidyl arginine deiminases | 8.33e-04 | 5 | 167 | 2 | 677 | |
| Coexpression | GSE37301_CD4_TCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN | TRAF1 HIVEP1 CD83 ARID5A SEMA4A VARS1 TCF7 CBX4 CBLB CDC14A SLC20A1 | 2.15e-06 | 180 | 262 | 11 | M8898 |
| Coexpression | GEORGES_TARGETS_OF_MIR192_AND_MIR215 | NCOA3 POGLUT3 WWC3 HJURP MRPL43 AASDHPPT EXTL2 CD83 TMC3 NKRF CEMIP2 CRLF3 ARHGAP29 UNG GNRH1 TCF7 TROAP ERICH5 CDC14A E2F8 NPHP3 TBC1D31 ATRNL1 TMPO LIMCH1 | 3.87e-06 | 892 | 262 | 25 | M18120 |
| Coexpression | GSE360_DC_VS_MAC_L_MAJOR_UP | EXPH5 PHLDA2 VARS1 FLNA UPF1 PTPN18 CRAT TRIM3 NCOR2 TLE1 KCTD20 | 5.93e-06 | 200 | 262 | 11 | M5181 |
| Coexpression | HALLMARK_APICAL_JUNCTION | TRAF1 MAP3K20 IRS1 ITGA9 VAV2 FLNC SHROOM2 CRAT CERCAM CDH1 EPB41L2 | 5.93e-06 | 200 | 262 | 11 | M5915 |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ITGA9 SCNN1G COBL MPP7 MPP3 NDNF DDR1 CARMIL1 PAXBP1 LIMCH1 CDH1 | 1.59e-08 | 186 | 264 | 11 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | EXPH5 SCNN1G COBL PLXNB1 MPP3 NDNF IRAG2 CERCAM LIMCH1 CDH1 FCAMR | 3.20e-08 | 199 | 264 | 11 | d43c605a4ff221cf78d91678c15d2ad20f831c7f |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ITGA9 SCNN1G COBL MPP7 MPP3 NDNF CARMIL1 LIMCH1 CDH1 PHACTR1 | 1.11e-07 | 177 | 264 | 10 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.17e-07 | 178 | 264 | 10 | c87945146b2734141f07b39d268e0d8086ee0364 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.37e-07 | 181 | 264 | 10 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | MAGI1 CCP110 SIPA1L3 SCNN1G COBL PGGHG CARMIL1 LIMCH1 CDH1 PHACTR1 | 1.68e-07 | 185 | 264 | 10 | 32b4e68e551d435a732f253f6ad83408c759a642 |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-07 | 187 | 264 | 10 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | COPD-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | NCOA3 HIVEP1 TRIO SIPA1L3 CD83 VAV2 CARMIL1 IGHM RUBCN PHACTR1 | 2.15e-07 | 190 | 264 | 10 | 1e85ee686ff6dd27c69415d524d54fa825b1daad |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.15e-07 | 190 | 264 | 10 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | Club_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | CYP2A6 FAT2 PTPRZ1 SCNN1G WNK2 DDR1 MUC16 GRAMD2B RIMS1 CDH1 | 2.48e-07 | 193 | 264 | 10 | 6582c0367052b9d10fb629c383ee0c55872afd2d |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | EXPH5 SCNN1G COBL PLXNB1 MPP3 NDNF CARMIL1 CERCAM LIMCH1 CDH1 | 3.14e-07 | 198 | 264 | 10 | 85f424cd9bb3117c9e322031024aabb87696ce47 |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.29e-07 | 199 | 264 | 10 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | MAGI1 EXPH5 SIPA1L3 FREM2 COBL FHIT MPP7 LIMCH1 CDH1 PHACTR1 | 3.29e-07 | 199 | 264 | 10 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | MAP1B MAP3K20 IRS1 FNDC1 FLNA AFF2 GUCY1A2 PRELP ATRNL1 ATP1A4 | 3.45e-07 | 200 | 264 | 10 | f599e4b051ac3dad11ad437e98dc8ea6754cca53 |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.45e-07 | 200 | 264 | 10 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.45e-07 | 200 | 264 | 10 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | MAP1B MAP3K20 IRS1 ITGA9 FNDC1 NDNF FLNA PRELP ATRNL1 ATP1A4 | 3.45e-07 | 200 | 264 | 10 | 8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | EXPH5 FAT2 PTPRZ1 HECTD1 PLXNB1 DDR1 ARHGEF12 MUC16 CDH1 AHNAK2 | 3.45e-07 | 200 | 264 | 10 | ecbe89ff95d046155b984c8c150e0b9e7278f839 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.28e-07 | 161 | 264 | 9 | a7e09cf2ca6cd70d40d08440fe9c5ab9befa1b79 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.28e-07 | 161 | 264 | 9 | 08920a716f6ec62538e361211455a30ad726d7be | |
| ToppCell | Control-B_naive-11|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.74e-07 | 126 | 264 | 8 | 319a4c325e0e5c14bb49a143b8924c554f834cc0 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 9.64e-07 | 173 | 264 | 9 | d1e47c87bd4750801f3531f66a56c5dccb4ea64c | |
| ToppCell | P03-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.11e-06 | 176 | 264 | 9 | f3a54038cde58326f1caed96ecca33c141bcc8b3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-06 | 177 | 264 | 9 | 88403b055eb9fdf96e4695fb6e0d78179e30a1e3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-06 | 177 | 264 | 9 | 8903aeaab61abd81a148ea623038c5114b8a183b | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.61e-06 | 184 | 264 | 9 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.61e-06 | 184 | 264 | 9 | cb15d6bae52c5ec251c2235859dc7e65f630ae23 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.61e-06 | 184 | 264 | 9 | bde4eaabd3e9bdaed23867d23a919b9d84b52d4b | |
| ToppCell | Control-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | 1.68e-06 | 185 | 264 | 9 | 6814b3c94c7558443c038a227b5c8563d2cfeac4 | |
| ToppCell | IPF-Epithelial-Club|World / Disease state, Lineage and Cell class | 2.19e-06 | 191 | 264 | 9 | 3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.19e-06 | 191 | 264 | 9 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.28e-06 | 192 | 264 | 9 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | Control-Epithelial-Club|Control / Disease state, Lineage and Cell class | 2.28e-06 | 192 | 264 | 9 | d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.38e-06 | 193 | 264 | 9 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-06 | 193 | 264 | 9 | 5fb7808dd971c1cc64c2bd4f8f1de646fb2d77f4 | |
| ToppCell | Club_cells|World / lung cells shred on cell class, cell subclass, sample id | 2.38e-06 | 193 | 264 | 9 | 9d3165dc5763a07a7d873f497624d9d6528fa2db | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.38e-06 | 193 | 264 | 9 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.71e-06 | 196 | 264 | 9 | 24d64b67aa9b0e8215ad06f9101c1314b3483620 | |
| ToppCell | Epithelial-A_(AT1)|World / shred on cell class and cell subclass (v4) | 2.71e-06 | 196 | 264 | 9 | 484bbc6b1f58bc260964babb949d14f5df101393 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.71e-06 | 196 | 264 | 9 | fd18a9ae8401121ae276adff1a85d5f938e2df91 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.71e-06 | 196 | 264 | 9 | 9790340c25f446ec655f5a0b64ec3bb44ed2e1bd | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.71e-06 | 196 | 264 | 9 | b9ceceeacbcf81976ce92adf044f0d0aa132632b | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | CYP2A6 CYP2A13 TRAF3IP1 MMP10 MAP3K19 DNAH3 MUC16 CDH1 AHNAK2 | 2.82e-06 | 197 | 264 | 9 | 5c4cee914baf7cb43e9cb99cc9e3ae823856dc15 |
| ToppCell | COVID-19-Epithelial-Club,_Basal_cells|Epithelial / Condition, Lineage and Cell class | 2.82e-06 | 197 | 264 | 9 | 78ed2810e5a765327e7a6da0ca5d4854bf7a0b6f | |
| ToppCell | Mild_COVID-19-Epithelial-Basal/Club|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.82e-06 | 197 | 264 | 9 | 4cc5b778e1e2c6c149160fa147c172977c0fa8eb | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.94e-06 | 198 | 264 | 9 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.06e-06 | 199 | 264 | 9 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | BAL-Severe-cDC_10|Severe / Compartment, Disease Groups and Clusters | 3.06e-06 | 199 | 264 | 9 | 54bdadd04abaf8caa948b0177c037bc089ca07e6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.06e-06 | 199 | 264 | 9 | 85bb28369e0568b7b3bda095722102fc793f60ef | |
| ToppCell | mild-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.06e-06 | 199 | 264 | 9 | cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.06e-06 | 199 | 264 | 9 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 3.19e-06 | 200 | 264 | 9 | c5e051f1aac8dda376c342a9932785a23450e073 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.19e-06 | 200 | 264 | 9 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.19e-06 | 200 | 264 | 9 | 87827041663013f5e7273168dc8709d69840e7ce | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 3.19e-06 | 200 | 264 | 9 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.19e-06 | 200 | 264 | 9 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Intermediate|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 3.19e-06 | 200 | 264 | 9 | a3fcd901cb281920f1bafdfd676399a6dc37355e | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.19e-06 | 200 | 264 | 9 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.19e-06 | 200 | 264 | 9 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo4_Rxfp1_Chat|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.13e-06 | 155 | 264 | 8 | 3b8def9e8f66511736ea37f259511f7c8b7743af | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.16e-06 | 167 | 264 | 8 | a35ace2c722936d2a3e1f0826e5b6ec6b1340d2b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.16e-06 | 167 | 264 | 8 | 83969c36ac44b96afc9aa09400a99fa2b487f7ff | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_activated|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 7.81e-06 | 169 | 264 | 8 | e68e6c24606fd46eca6f86bb63fa86ea17879ae2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.52e-06 | 171 | 264 | 8 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.52e-06 | 171 | 264 | 8 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | critical-Epithelial-unknown_epithelial|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.27e-06 | 173 | 264 | 8 | 4144b1cdefa8c37b6ac7a6d249fa5292ffb2b8b2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.27e-06 | 173 | 264 | 8 | ecbf7167d4bec685e3460d826318544946f5f5c2 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l4|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.27e-06 | 173 | 264 | 8 | 42272af45547422ef85e35f4a4c7d269e9ed7a8a | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.27e-06 | 173 | 264 | 8 | 464267a2ff3f5c387b6c9c6fa4dab135a221f448 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.27e-06 | 173 | 264 | 8 | b8dc978c52de64afba21ff6cb32e79f07167448e | |
| ToppCell | ASK428-Immune-B_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.01e-05 | 175 | 264 | 8 | e0979e5795a49b4e5c9b88e7fe6b7bda7a413a6c | |
| ToppCell | Club_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 1.05e-05 | 176 | 264 | 8 | 88c4ed0ab4a4ede8cad21385d799b723b5786cd9 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.05e-05 | 176 | 264 | 8 | 05ec715439f2eb1696f5d8855da0dd1dd70effd0 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-basal_late|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.14e-05 | 178 | 264 | 8 | 03f22485074b3cbf9a6ad4d543c5bbfa826dc741 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-05 | 179 | 264 | 8 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | Severe-B_naive-12|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.24e-05 | 180 | 264 | 8 | bc20e581d37cba72b71ef62df60475a0ccee9994 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.29e-05 | 181 | 264 | 8 | ab0f300d14b62cef57f1b0bdae143b8dfe8e6975 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.34e-05 | 182 | 264 | 8 | ad4d74d8b19976e1ccc3c5ba8013199338cf6fd8 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.34e-05 | 182 | 264 | 8 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | IPF-Epithelial-ATI|World / Disease state, Lineage and Cell class | 1.39e-05 | 183 | 264 | 8 | 31fef35ecf30162662f24d335d8f0cceacc07039 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-05 | 183 | 264 | 8 | 3c516fe5083f02bad1f464ed284010b4131a833c | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.39e-05 | 183 | 264 | 8 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-05 | 183 | 264 | 8 | 9c2689d76fc6d30f5ab093428aa669d0a98953cf | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-basal_proximal|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.45e-05 | 184 | 264 | 8 | 575de705053da8b289670b5c40c1627c0833b5ed | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.45e-05 | 184 | 264 | 8 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-luminal_bladder_epithelial_cell_(umbrella_cell)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-05 | 184 | 264 | 8 | 382b1e90b3f437af596750669c0465a169d97095 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.45e-05 | 184 | 264 | 8 | e6bf826be31e1723e24c366fc5a1cee9b15589bc | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 1.51e-05 | 185 | 264 | 8 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | Control-Epithelial_alveolar|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-05 | 185 | 264 | 8 | 3937e026add96a396122139daf8011cfbc60e75c | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-05 | 185 | 264 | 8 | c82eab551f65ecebe6db908eda9f9eb3414693c7 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.51e-05 | 185 | 264 | 8 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.57e-05 | 186 | 264 | 8 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | COPD-Epithelial-ATI|COPD / Disease state, Lineage and Cell class | 1.57e-05 | 186 | 264 | 8 | df0977f6f48a2d4e11b59971f098b01204242f0f | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-05 | 186 | 264 | 8 | d1d01ce46e62944aa9864eda47e8401b5f0d2bdc | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.57e-05 | 186 | 264 | 8 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.57e-05 | 186 | 264 | 8 | bb0bfe9a015151be08a6ffc5d82896d0556d76de | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.63e-05 | 187 | 264 | 8 | db2974e2e87ac9f1c2407a371d5ed89af09fc9b7 | |
| ToppCell | COVID-19_Mild-Neu_4|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 1.63e-05 | 187 | 264 | 8 | 714851e757c71c559ee6413a3f61d6c117c79ad2 | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.63e-05 | 187 | 264 | 8 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | IPF-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 1.63e-05 | 187 | 264 | 8 | af1327559f7e01bec070881cae52834917c3da65 | |
| Drug | Aceclofenac [89796-99-6]; Up 200; 11.2uM; PC3; HT_HG-U133A | NCOA3 HIVEP1 LRCH1 CEMIP2 PLXNB1 BICRA SPACA9 SHROOM2 CDC14A NCOR2 CTDP1 MYH15 | 2.84e-06 | 196 | 260 | 12 | 7269_UP |
| Drug | N'-nitrosoanatabine | 5.84e-06 | 4 | 260 | 3 | ctd:C032978 | |
| Drug | polybrominated biphenyl | 1.03e-05 | 44 | 260 | 6 | CID000042948 | |
| Drug | 2-phenylindole | 1.10e-05 | 13 | 260 | 4 | CID000013698 | |
| Drug | Nadolol [42200-33-9]; Up 200; 13uM; MCF7; HT_HG-U133A | TRAF3IP1 SEC24A ADM SYNJ2 PLXNB1 TEX14 CDC14A NCOR2 MED25 LIMCH1 AHNAK2 | 1.52e-05 | 194 | 260 | 11 | 4139_UP |
| Drug | Hydrocortisone base [50-23-7]; Up 200; 11uM; MCF7; HT_HG-U133A | KMT2B TRAF3IP1 FRMD1 ADM VAV2 JCAD FAT4 GSDMD ATRNL1 NEURL1 MED25 | 1.52e-05 | 194 | 260 | 11 | 3284_UP |
| Drug | Fluorometholone [426-13-1]; Up 200; 10.6uM; MCF7; HT_HG-U133A | TRIO ITGA9 FRMD1 MAN1A2 PLXNB1 H6PD CRAT GUCY1A2 BAZ2A CNTNAP2 MED25 | 1.60e-05 | 195 | 260 | 11 | 6071_UP |
| Drug | Sulfanilamide [63-74-1]; Down 200; 23.2uM; PC3; HT_HG-U133A | ABCA2 TRAF3IP1 SIPA1L3 APBB1 H6PD SHROOM2 CDC14A BAZ2A MED25 TMPO LRP6 | 1.76e-05 | 197 | 260 | 11 | 4474_DN |
| Drug | Carbinoxamine maleate salt [3505-38-2]; Up 200; 9.8uM; HL60; HT_HG-U133A | TRAF1 MAN1A2 TMCC2 SYNM SPACA9 CDC14A TRIM3 TLE1 NEURL1 KCTD20 RIMS1 | 1.84e-05 | 198 | 260 | 11 | 2725_UP |
| Drug | Oxaprozin [21256-18-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A | MAGI1 FRMD1 MPP3 ARHGEF12 CDC14A TRIM3 NCOR2 LRP6 DEPDC5 LIMCH1 AQR | 1.84e-05 | 198 | 260 | 11 | 3876_DN |
| Drug | Acenocoumarol [152-72-7]; Up 200; 11.4uM; PC3; HT_HG-U133A | NCOA3 SYNJ2 PLXNB1 APBB1 NSD1 SPACA9 ATP13A2 GSDMD NEURL1 CNTNAP2 CABIN1 | 2.02e-05 | 200 | 260 | 11 | 2077_UP |
| Drug | N'-nitrosoanabasine | 2.87e-05 | 6 | 260 | 3 | ctd:C010257 | |
| Disease | Malignant neoplasm of breast | NCOA3 XIRP1 ADAT3 MAN2C1 CYP2D6 ESRRA RPS8 ITGA9 SYNJ2 ARHGAP29 NHS DLEC1 MMP10 PLXNB1 RCE1 GPI FLNA H6PD SHROOM2 CD2 GUCY1A2 TREM1 CDH1 PADI3 | 1.90e-05 | 1074 | 252 | 24 | C0006142 |
| Disease | cotinine measurement, cigarettes per day measurement | 7.27e-05 | 2 | 252 | 2 | EFO_0006525, EFO_0007813 | |
| Disease | Colorectal Carcinoma | CYP2A6 MAP1B F5 AXIN2 SACS MCM3AP SCNN1G UNG IQUB FLNC DNAH3 CDC14A CCND2 GMCL2 GUCY1A2 NEURL1 CDH1 | 1.26e-04 | 702 | 252 | 17 | C0009402 |
| Disease | Neurodegeneration with brain iron accumulation | 1.65e-04 | 13 | 252 | 3 | cv:C2931845 | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 2.17e-04 | 3 | 252 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 2.17e-04 | 3 | 252 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | aspartate aminotransferase measurement | CCDC125 MAGI1 CYP2A6 WWC3 PEPD PHLDA2 ITGA9 TMCC2 ARHGAP29 VARS1 WNK2 CARMIL1 NSD1 PTPN18 NCOR2 NPHP3 BAZ2A CNTNAP2 HMGXB3 | 3.10e-04 | 904 | 252 | 19 | EFO_0004736 |
| Disease | hematological measurement | 4.31e-04 | 4 | 252 | 2 | EFO_0004503 | |
| Disease | KDEL motif-containing protein 2 measurement | 4.31e-04 | 4 | 252 | 2 | EFO_0801740 | |
| Disease | invasive lobular carcinoma (is_implicated_in) | 4.31e-04 | 4 | 252 | 2 | DOID:3457 (is_implicated_in) | |
| Disease | squamous cell lung carcinoma | 5.64e-04 | 165 | 252 | 7 | EFO_0000708 | |
| Disease | acute myeloid leukemia (is_implicated_in) | 7.78e-04 | 84 | 252 | 5 | DOID:9119 (is_implicated_in) | |
| Disease | platelet component distribution width | IRS1 LRCH1 SYNJ2 CRLF3 TMCC2 KIF2A DLEC1 VAV2 MPP3 JCAD CARMIL1 U2SURP ZNF496 NCOR2 MEIOC BAZ2A | 8.43e-04 | 755 | 252 | 16 | EFO_0007984 |
| Disease | cotinine measurement | 9.61e-04 | 23 | 252 | 3 | EFO_0007813 | |
| Disease | periventricular nodular heterotopia (is_implicated_in) | 1.07e-03 | 6 | 252 | 2 | DOID:0050454 (is_implicated_in) | |
| Disease | migraine disorder | HJURP LRCH1 EHMT2 JCAD NSD1 NCOR2 HMGXB3 LIMCH1 EPB41L2 PHACTR1 | 1.07e-03 | 357 | 252 | 10 | MONDO_0005277 |
| Disease | myeloid white cell count | CCDC125 TRAF1 POGLUT3 RC3H1 EML6 NAIP PEPD SREBF1 EXTL2 NCLN GGT5 VAV2 PLXNB1 JCAD ARHGEF12 CBX4 CDC14A ATP1A4 | 1.24e-03 | 937 | 252 | 18 | EFO_0007988 |
| Disease | Gemistocytic astrocytoma | 1.38e-03 | 26 | 252 | 3 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 1.38e-03 | 26 | 252 | 3 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 1.38e-03 | 26 | 252 | 3 | C0334582 | |
| Disease | Adenocarcinoma of large intestine | 1.42e-03 | 96 | 252 | 5 | C1319315 | |
| Disease | Helicobacter Infections | 1.48e-03 | 7 | 252 | 2 | C0079487 | |
| Disease | myoclonic-atonic epilepsy (implicated_via_orthology) | 1.48e-03 | 7 | 252 | 2 | DOID:0060475 (implicated_via_orthology) | |
| Disease | Autosomal Dominant Nocturnal Frontal Lobe Epilepsy | 1.48e-03 | 7 | 252 | 2 | C3696898 | |
| Disease | Periventricular Nodular Heterotopia | 1.48e-03 | 7 | 252 | 2 | C1868720 | |
| Disease | colon adenoma (is_marker_for) | 1.48e-03 | 7 | 252 | 2 | DOID:0050912 (is_marker_for) | |
| Disease | Anaplastic astrocytoma | 1.55e-03 | 27 | 252 | 3 | C0334579 | |
| Disease | blood cobalt measurement | 1.78e-03 | 101 | 252 | 5 | EFO_0007577 | |
| Disease | nasopharyngeal neoplasm | 1.94e-03 | 151 | 252 | 6 | EFO_0004252 | |
| Disease | QT interval, response to tricyclic antidepressant | 1.97e-03 | 8 | 252 | 2 | EFO_0004682, EFO_0007916 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 1.97e-03 | 8 | 252 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 2.08e-03 | 63 | 252 | 4 | DOID:0050866 (is_marker_for) | |
| Disease | Lung Neoplasms | 2.10e-03 | 265 | 252 | 8 | C0024121 | |
| Disease | Malignant neoplasm of lung | 2.15e-03 | 266 | 252 | 8 | C0242379 | |
| Disease | Tendinopathy | 2.51e-03 | 9 | 252 | 2 | EFO_1001434 | |
| Disease | Cleft palate with cleft lip | 2.51e-03 | 9 | 252 | 2 | C0158646 | |
| Disease | response to aromatase inhibitor | 2.54e-03 | 32 | 252 | 3 | GO_0061477 | |
| Disease | Colorectal Neoplasms | 2.75e-03 | 277 | 252 | 8 | C0009404 | |
| Disease | Spinocerebellar Ataxia Type 2 | 3.03e-03 | 34 | 252 | 3 | C0752121 | |
| Disease | Spinocerebellar Ataxia Type 1 | 3.03e-03 | 34 | 252 | 3 | C0752120 | |
| Disease | Spinocerebellar Ataxia Type 5 | 3.03e-03 | 34 | 252 | 3 | C0752123 | |
| Disease | Spinocerebellar Ataxia Type 7 | 3.03e-03 | 34 | 252 | 3 | C0752125 | |
| Disease | Spinocerebellar Ataxia Type 6 (disorder) | 3.03e-03 | 34 | 252 | 3 | C0752124 | |
| Disease | Ataxia, Spinocerebellar | 3.03e-03 | 34 | 252 | 3 | C0087012 | |
| Disease | mitochondrial complex I deficiency (implicated_via_orthology) | 3.12e-03 | 10 | 252 | 2 | DOID:0060536 (implicated_via_orthology) | |
| Disease | Uterine leiomyoma, estrogen-receptor negative breast cancer | 3.12e-03 | 10 | 252 | 2 | EFO_1000650, HP_0000131 | |
| Disease | 3-methyl-2-oxobutyrate measurement | 3.12e-03 | 10 | 252 | 2 | EFO_0021020 | |
| Disease | Spinocerebellar Ataxia Type 4 | 3.29e-03 | 35 | 252 | 3 | C0752122 | |
| Disease | asthma (implicated_via_orthology) | 3.29e-03 | 35 | 252 | 3 | DOID:2841 (implicated_via_orthology) | |
| Disease | Polydactyly | 3.37e-03 | 117 | 252 | 5 | C0152427 | |
| Disease | pentachlorophenol measurement | 3.56e-03 | 73 | 252 | 4 | EFO_0022071 | |
| Disease | parathion measurement | 3.56e-03 | 73 | 252 | 4 | EFO_0022070 | |
| Disease | potassium chromate measurement | 3.56e-03 | 73 | 252 | 4 | EFO_0022072 | |
| Disease | mercuric chloride measurement | 3.56e-03 | 73 | 252 | 4 | EFO_0022068 | |
| Disease | heptachlor epoxide measurement | 3.56e-03 | 73 | 252 | 4 | EFO_0022067 | |
| Disease | methoxychlor measurement | 3.56e-03 | 73 | 252 | 4 | EFO_0022069 | |
| Disease | 4,6-dinitro-o-cresol measurement | 3.56e-03 | 73 | 252 | 4 | EFO_0022053 | |
| Disease | 2,4,5-trichlorophenol measurement | 3.56e-03 | 73 | 252 | 4 | EFO_0022052 | |
| Disease | azinphos methyl measurement | 3.56e-03 | 73 | 252 | 4 | EFO_0022055 | |
| Disease | aldrin measurement | 3.56e-03 | 73 | 252 | 4 | EFO_0022054 | |
| Disease | dicofol measurement | 3.56e-03 | 73 | 252 | 4 | EFO_0022060 | |
| Disease | disulfoton measurement | 3.56e-03 | 73 | 252 | 4 | EFO_0022062 | |
| Disease | dieldrin measurement | 3.56e-03 | 73 | 252 | 4 | EFO_0022061 | |
| Disease | endrin measurement | 3.56e-03 | 73 | 252 | 4 | EFO_0022064 | |
| Disease | endosulfan measurement | 3.56e-03 | 73 | 252 | 4 | EFO_0022063 | |
| Disease | heptachlor measurement | 3.56e-03 | 73 | 252 | 4 | EFO_0022066 | |
| Disease | ethion measurement | 3.56e-03 | 73 | 252 | 4 | EFO_0022065 | |
| Disease | chlorpyrifos measurement | 3.56e-03 | 73 | 252 | 4 | EFO_0022057 | |
| Disease | cadmium chloride measurement | 3.56e-03 | 73 | 252 | 4 | EFO_0022056 | |
| Disease | diazinon measurement | 3.56e-03 | 73 | 252 | 4 | EFO_0022059 | |
| Disease | dibutyl phthalate measurement | 3.56e-03 | 73 | 252 | 4 | EFO_0022058 | |
| Disease | environmental exposure measurement | 3.56e-03 | 73 | 252 | 4 | EFO_0008360 | |
| Disease | lung squamous cell carcinoma (is_marker_for) | 3.57e-03 | 36 | 252 | 3 | DOID:3907 (is_marker_for) | |
| Disease | lung cancer (is_implicated_in) | 3.74e-03 | 74 | 252 | 4 | DOID:1324 (is_implicated_in) | |
| Disease | DDT metabolite measurement | 3.74e-03 | 74 | 252 | 4 | EFO_0007886 | |
| Disease | blood nickel measurement | 3.75e-03 | 120 | 252 | 5 | EFO_0007583 | |
| Disease | melanoma-derived growth regulatory protein measurement | 3.80e-03 | 11 | 252 | 2 | EFO_0008229 | |
| Disease | interleukin-6 measurement, response to stimulus | 3.80e-03 | 11 | 252 | 2 | EFO_0004810, GO_0050896 | |
| Disease | Leukemia, Myelocytic, Acute | 3.81e-03 | 173 | 252 | 6 | C0023467 | |
| Disease | Rheumatoid Arthritis | 3.92e-03 | 174 | 252 | 6 | C0003873 | |
| Disease | Acute Myeloid Leukemia, M1 | 4.46e-03 | 125 | 252 | 5 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 4.46e-03 | 125 | 252 | 5 | C1879321 | |
| Disease | Oligodontia | 4.53e-03 | 12 | 252 | 2 | C4082304 | |
| Disease | Renal dysplasia and retinal aplasia (disorder) | 4.53e-03 | 12 | 252 | 2 | C0403553 | |
| Disease | stomach carcinoma (is_implicated_in) | 4.53e-03 | 12 | 252 | 2 | DOID:5517 (is_implicated_in) | |
| Disease | hepatocellular carcinoma (is_marker_for) | 4.54e-03 | 301 | 252 | 8 | DOID:684 (is_marker_for) | |
| Disease | Inherited neuropathies | 4.82e-03 | 40 | 252 | 3 | C0598589 | |
| Disease | bilirubin measurement | SIPA1L3 HJURP PHLDA2 UGT2B10 FAT4 CARMIL1 CRAT CCND2 ORMDL1 PHACTR1 | 4.96e-03 | 442 | 252 | 10 | EFO_0004570 |
| Disease | Mesothelioma | 5.16e-03 | 41 | 252 | 3 | C0025500 | |
| Disease | gallbladder cancer (is_implicated_in) | 5.33e-03 | 13 | 252 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | Intellectual Disability | 5.36e-03 | 447 | 252 | 10 | C3714756 | |
| Disease | Cardiomegaly | 5.40e-03 | 82 | 252 | 4 | C0018800 | |
| Disease | Cardiac Hypertrophy | 5.40e-03 | 82 | 252 | 4 | C1383860 | |
| Disease | total blood protein measurement | NCOA3 PEPD CEMIP2 ARHGAP29 DNAH3 TCF7 ARHGEF12 CCND2 NCOR2 SLC25A10 | 5.52e-03 | 449 | 252 | 10 | EFO_0004536 |
| Disease | Mammary Carcinoma, Human | NCOA3 MAN2C1 CYP2D6 ESRRA RPS8 SYNJ2 GPI FLNA H6PD GUCY1A2 CDH1 | 5.78e-03 | 525 | 252 | 11 | C4704874 |
| Disease | Mammary Neoplasms, Human | NCOA3 MAN2C1 CYP2D6 ESRRA RPS8 SYNJ2 GPI FLNA H6PD GUCY1A2 CDH1 | 5.78e-03 | 525 | 252 | 11 | C1257931 |
| Disease | Mammary Neoplasms | NCOA3 MAN2C1 CYP2D6 ESRRA RPS8 SYNJ2 GPI FLNA H6PD GUCY1A2 CDH1 | 5.94e-03 | 527 | 252 | 11 | C1458155 |
| Disease | Parkinson Disease | 6.13e-03 | 85 | 252 | 4 | C0030567 | |
| Disease | dystonia (is_implicated_in) | 6.18e-03 | 14 | 252 | 2 | DOID:543 (is_implicated_in) | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 6.18e-03 | 14 | 252 | 2 | DOID:898 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KVTPRAQRPGAHAED | 391 | Q99952 | |
| ARKRHAPSPEPAVQG | 16 | P13051 | |
| ERPSKNSHPVQVGRI | 71 | Q9NP99 | |
| IHFPIRGNKTSPRAH | 916 | Q13075 | |
| HSEDGARPRLQPSKN | 411 | A9YTQ3 | |
| PGERPSHSLSRDFKN | 1946 | Q68DN1 | |
| AQPHLKRVRPSRDAG | 71 | Q96EY9 | |
| FSGLHPTNFPIEKTR | 641 | Q9Y5B0 | |
| REARRANPHFKSFPV | 76 | P59051 | |
| ANPHFKSFPVLEARG | 81 | P59051 | |
| RKPDGSRHQDVPSQD | 246 | Q9NRN7 | |
| PKGLTENSRHRLTPQ | 301 | Q03989 | |
| FQGLLRTTLPHPKAE | 2026 | Q96N23 | |
| NNVAPLKTHFRTPRP | 1216 | P78357 | |
| IDVSPKHVGFATIPR | 471 | P11509 | |
| LGHSDFPTTVPRLAK | 591 | Q96Q42 | |
| TKGHPRAVSQPFRLS | 421 | Q9UNH5 | |
| QPRHLKSPVRGQDSE | 1201 | Q9UIF9 | |
| VELHDPPRGRNKATA | 661 | P51816 | |
| VATEERGRKPHQIPA | 256 | P06729 | |
| VSLDFPLNVRKGHPL | 636 | Q08345 | |
| KQRTFQPPATGHKRS | 236 | P57764 | |
| TPKFSIQRHSPLGFA | 4646 | Q6V0I7 | |
| APRSHGPTVRKFAKV | 836 | C9J069 | |
| EPRSRDLSPISKGFH | 241 | O60359 | |
| VKANGQVSLPHFPRT | 341 | Q9Y2T1 | |
| SRFKAHQDALPRLPV | 26 | P43155 | |
| LDGKRQRFHSPHQEP | 86 | Q6PIY7 | |
| TTSPEGQPKVHRARK | 171 | Q96KQ7 | |
| QRKALSHVPGAARPF | 216 | Q17RM4 | |
| RPQALTDGPREHSKS | 191 | O00213 | |
| EPFPTTRKNGERPSH | 1336 | O60306 | |
| RPTKLDSNGQSPFHL | 46 | Q8N283 | |
| RDRVAKGSQGPLPFH | 86 | Q9UBX3 | |
| HKEQPVRGSTFPSNL | 466 | Q96BY7 | |
| QGSLFPSPILRAKHF | 1321 | Q9P241 | |
| RTLVSSKPQAHGAPA | 161 | P35318 | |
| KPIRHGSILNRESPT | 16 | Q9NZN5 | |
| DGTRDHQFPAKRPRL | 671 | Q8NCD3 | |
| HQFPAKRPRLSEPQG | 676 | Q8NCD3 | |
| AFQPGHKRTPSEAER | 401 | Q9Y6R0 | |
| EPRFPQASKTSIGHV | 231 | Q5TC82 | |
| ISLFRAAVPHTGRKN | 346 | Q9Y5X5 | |
| ESRHGAVKSPFLPLA | 216 | Q96L73 | |
| TTPGFRIPLKNAHDA | 146 | Q9Y5H1 | |
| GKSTLFVPRLPASHA | 91 | P12955 | |
| QVKGSRRPKFHARPE | 716 | A6NNM3 | |
| QVKGSRRPKFHARPE | 716 | A6NJZ7 | |
| ARPTGFIHTLKEPQI | 136 | Q1A5X6 | |
| KPPREGTLQHAFLRE | 326 | Q969V3 | |
| HDFGLRTPPLIRTQK | 311 | Q9UGN5 | |
| PSKNVRHRGRVSPSD | 1401 | Q9HCM3 | |
| RFLAGVPTPKSHLQL | 86 | P30279 | |
| ERAFLPVTSPNKHLG | 181 | Q01151 | |
| HTLGFPPTIRKIDAA | 376 | P09238 | |
| HKTLPVVFDSPRNRG | 361 | Q9UM07 | |
| AVPLFKLHNRSAPRD | 376 | O75140 | |
| IPNEAAHRGTIRPVK | 10436 | Q8WXI7 | |
| ERPRADTGHAFLAKP | 1946 | Q9Y618 | |
| PFETPDQGKARLLTH | 71 | Q53FV1 | |
| KPARIVAGHEPERTN | 91 | Q8TDR0 | |
| GVRRSFRKSPEHPVD | 2086 | Q14667 | |
| GDSRSQKPELQPHRS | 416 | A5PL33 | |
| QRRISHEGSPVKPVA | 411 | Q96II8 | |
| HSARFSPEVPGQKIL | 86 | P46821 | |
| NFDVGHVPIRLPRTK | 386 | P50579 | |
| ANLKQDAGRSSRHPP | 1461 | Q96QZ7 | |
| KVPPGSRATFQVEHL | 2866 | Q8IWI9 | |
| LRQDPKTGSFPEHIT | 1916 | Q6PRD1 | |
| GNKRNHEPFIAPERF | 86 | Q7Z5Y7 | |
| PSIESKVLRFPNRLH | 316 | Q9Y2Z2 | |
| PEAQHRKTPTFLGAT | 111 | Q5MY95 | |
| FPTGDHKQRPSARNL | 736 | Q9P266 | |
| ARRQGHVNLPPLEFK | 2496 | Q2LD37 | |
| APVGSPALKREHFQV | 291 | Q5SZK8 | |
| REGRLAIKPFHPSAN | 1806 | O60318 | |
| REDNKSILLNPGPRH | 581 | Q5JUK3 | |
| GDPAEHPLLRRKSLQ | 1071 | Q5JUK3 | |
| IKSNVPELRGHFPLS | 1351 | Q8IY21 | |
| PHNKPLFQALIDGSR | 311 | Q13191 | |
| PDQIVGFVPRKHVST | 171 | Q9UBQ6 | |
| DGRREVRSPTKAPHL | 591 | O43491 | |
| ARAIRPPRHFTGGKI | 1046 | Q12766 | |
| PRDHPAVIKRRFTSV | 61 | Q9Y256 | |
| KVRASPAGQLPSRFH | 101 | Q12796 | |
| DPKVHSIFPARGPRA | 1161 | O43157 | |
| KGTPFSQRPSVHALD | 1561 | Q9ULL4 | |
| QIRGFHLPPSKLSSL | 346 | Q9NYQ8 | |
| PRRPFLGSHSVDKSQ | 86 | Q6ZS72 | |
| IFKHGTVASRPPVQI | 171 | Q8IUI8 | |
| PAGTSEPHRALKRQA | 56 | Q7L5A3 | |
| EPHRALKRQAPSTEG | 61 | Q7L5A3 | |
| AEAHIPGSPFKATIR | 1136 | Q14315 | |
| LPNRHIGISFTPKEV | 1996 | Q14315 | |
| ANPRAGLIPSKHFQE | 281 | Q5T2T1 | |
| RPLEPRADQHTFGSK | 56 | P57055 | |
| RQRLGKRPHSPEKAF | 491 | Q53F19 | |
| RQAVVKGSLPHPFAL | 216 | O75581 | |
| RKLKEFPRTAAPGHD | 81 | Q9Y2L9 | |
| RSFQAKPSPKLGRHV | 266 | Q8TB73 | |
| PAKDVSPRRHVATIF | 1606 | Q8NEV8 | |
| RGIHFSIVSPRKLPA | 176 | Q71SY5 | |
| RNLEPHGKQPSLRAA | 86 | O95568 | |
| RLLPHKVFEGNRPTN | 461 | P06744 | |
| APKRTGPHLRFEISS | 2406 | Q9UMN6 | |
| NRVTGNFKHASPILP | 296 | P42167 | |
| GPQTDDPRNKHKFRL | 91 | P05129 | |
| QSRLSLLPGHKVSFP | 666 | Q32M88 | |
| TVAAPAHGKAAPRRE | 136 | A6NEQ2 | |
| PKGRHVFATPVLSID | 1306 | P23471 | |
| FTPHDNEPGKGRLVR | 241 | Q9Y5B6 | |
| HKTLPVVFDSPRNGE | 361 | Q9ULW8 | |
| SLPRSFKHTQRPGEP | 766 | P35568 | |
| PFETPDQGKARLLTH | 71 | Q9P0S3 | |
| QTKNIPPHDDRGARA | 1446 | Q6R327 | |
| PGTRKIELFGRPHNV | 526 | Q86U44 | |
| AHERRLPAGPKVNRT | 166 | Q14953 | |
| GTHTPPIRRRSKFAN | 101 | Q9C0D0 | |
| HAAPRATDQPVIRGK | 1196 | Q86UR5 | |
| ATDQPVIRGKHPARS | 1201 | Q86UR5 | |
| PGAVFKCRVHTNPDR | 81 | Q13797 | |
| GRNKPHTPFRASKLT | 496 | O00139 | |
| ESISPGDFHRKLPRT | 556 | Q52LW3 | |
| PKRFTAQGLPDLNHS | 471 | Q92900 | |
| PTLHRERQGLSPKEA | 231 | Q8N878 | |
| GLVSSILHPRPINFK | 406 | Q9NQ11 | |
| QGSSFALPQKRPHPR | 11 | Q8WWV6 | |
| LSFALVNRKPVVPGH | 21 | P49789 | |
| RFTRRGVDPAPLAKH | 216 | Q9ULT8 | |
| REHQKGRPTSTNPIA | 356 | P48735 | |
| HRSRKRSDGKNFSPP | 46 | Q86Z20 | |
| VQRPSDAHTKPRPAL | 1956 | Q9Y6J0 | |
| HKGPPIDSSDIRQRQ | 2241 | Q4AC94 | |
| IDVSPKHVGFATIPR | 471 | Q16696 | |
| NLFSTRGKPNFTRHP | 381 | A0AVK6 | |
| QTISRPKGVALHRPD | 316 | P01871 | |
| RRGEASPKAPNHFRK | 101 | Q8IXT2 | |
| HPGPAFQRSKARETQ | 16 | Q8TD57 | |
| QPGSVGRLHFPKLRS | 151 | Q6ZN03 | |
| APQDFHPDRVKARGP | 666 | P21333 | |
| FLPAQHTVGSPRDRK | 331 | Q8TCT0 | |
| NHSGRPFRPNGLLDK | 166 | P10635 | |
| SPHSFPKGTQVIARN | 421 | Q14435 | |
| RSPQRGASLHRKEPI | 911 | Q4ZHG4 | |
| KAQPGSTDRHASPAR | 966 | Q4ZHG4 | |
| PSDHPLFQAKSARGV | 111 | P07902 | |
| GPHRKLSTQDRPAAI | 956 | O75128 | |
| APLRGRHTLSQVPNK | 56 | Q6ZV80 | |
| ERHPPADRTFKKAAG | 301 | O00257 | |
| RPQELKLCFSRHPTG | 721 | Q5VZ89 | |
| LGDPRSHPKLQNASR | 336 | P36269 | |
| SVIFQTRKDGSLPPH | 606 | Q9BZC7 | |
| PKPNLHRDVNRFGHS | 571 | Q5VV63 | |
| PRNNISLVKFGPHVS | 911 | Q9UHN6 | |
| NAPVHRLLSRQGTPK | 956 | O43303 | |
| ALNPHQSPDFKRSPR | 721 | Q9NYL2 | |
| QSPDFKRSPRDLHQP | 726 | Q9NYL2 | |
| PDPAGHLTLRDNRLK | 1006 | Q9NTJ4 | |
| RPIARKGHSPNIFGS | 206 | O60476 | |
| HNAGTQTVPKRIPER | 266 | Q8NA54 | |
| SPNKHVSVPDRITGR | 396 | Q9NWL6 | |
| PAPGQIALLKFSSHR | 176 | Q8IYX4 | |
| RILGSKQSEHRPSLP | 406 | Q12912 | |
| RTVFSHRKGKEVPPS | 401 | Q5VZK9 | |
| LPQQIRKAPTEGHTR | 901 | Q9UHC6 | |
| FFEAPRGKRHIIRPS | 1151 | Q6ZMW3 | |
| HQPRSPLRDLKGALE | 66 | P01148 | |
| HVTRPSKRPSKIGFD | 306 | Q5T4B2 | |
| FAQPKPHALGRESTV | 36 | Q6P6B1 | |
| KPTRADAHVNRVPEG | 301 | Q96HH9 | |
| RRELQKPDSFHSLTP | 321 | O95479 | |
| NEKSLPQHRFPATGL | 131 | Q5H9B9 | |
| PKALLERFHQVPSGI | 956 | Q9NZM4 | |
| PGKRHRLQDFAVGPL | 1441 | Q9Y238 | |
| DKIRDGLHRPSSTPN | 491 | P60507 | |
| RPAANTKIGPRRIHT | 31 | P62241 | |
| RKPQESRGHVSPAED | 256 | Q92622 | |
| GPAHTKPLNRRSVLE | 126 | Q96BU1 | |
| RAFILHKADPVPNGL | 181 | Q8WUM9 | |
| VSEGKQPRFSHRIPL | 146 | P51170 | |
| RPAQAIGTQPRATKH | 181 | Q96E40 | |
| TLRVKGFNPIPHSRS | 4056 | Q9NZJ4 | |
| GPRKTAAPVNALVSH | 186 | P11474 | |
| PTRSGVLTIPQNHKF | 216 | Q56UN5 | |
| GVITVKRPLRFHNPQ | 81 | P12830 | |
| ERRKKSPREHFQAGP | 976 | Q9UPQ0 | |
| PFETPDQGKARLLTH | 71 | Q8N138 | |
| SHRVLSGTAPKDPRQ | 241 | Q96A99 | |
| TAHRKVPGAQLPTAA | 156 | Q9BZF2 | |
| APTNHRRPGEKRAST | 16 | Q8N9Y4 | |
| QHFGVAVPHTTRPRK | 411 | Q13368 | |
| KFESGSHPRRINVSP | 646 | P33402 | |
| RAPVPRTKASGTEHN | 141 | Q9GZR2 | |
| GKNVIHPFLSRSLPI | 561 | P26640 | |
| QRPIKTRSGPASELH | 741 | A2RUB1 | |
| HPFTNKPTTFRGLRP | 131 | Q8N983 | |
| KRQFGSAPPVRRLGH | 401 | Q8N2I9 | |
| LPGVPKSRLEHETNR | 806 | Q7Z5M5 | |
| GSFTSIRHPSPRQKE | 1026 | Q8IWB6 | |
| HRKPSPATRDGIIVN | 16 | Q96DN5 | |
| TSRRDFGPHKVAPVK | 71 | Q8IYX7 | |
| QRGSPHLLRKAPQDS | 191 | O75069 | |
| LPRHTFGLVQSKLFP | 41 | Q6UW68 | |
| HGQPSPSLEDAKLRR | 36 | Q8IUX1 | |
| RTLRHIAPGPKETSF | 1446 | O15061 | |
| TFQPGKAAERPSHRK | 1291 | O15056 | |
| SGHPKFPRVRHKSLQ | 996 | P12259 | |
| DHKRQGRPSISFRKP | 831 | Q6T4R5 | |
| QAGSKFHARPRFEPV | 46 | O15226 | |
| IRQKSFGPKHPSVAT | 1206 | Q7Z494 | |
| QVKGSRRPKFHARPE | 716 | Q9UFD9 | |
| VGALKPREEPNHRSS | 646 | O95486 | |
| VPGPNSKRANTHIRD | 791 | P21675 | |
| KGKRRSEAPPHIFAV | 161 | Q9Y2K3 | |
| HSKRPRFLAPNQASG | 6 | P0DPQ3 | |
| TEPGKPFVSVFRHLR | 321 | Q8NEA9 | |
| NRGSPKIASHQFSPV | 486 | Q9Y6Q9 | |
| TLRPGEKAPLSREQH | 721 | Q9H3S1 | |
| GALPFTPKNIRSHFQ | 731 | O60292 | |
| PFRESQPLHSKRPVS | 1121 | O60292 | |
| SPFGSIHPRDKQTVA | 371 | Q9HAT2 | |
| IFTIRLPKETPGQHF | 71 | Q6PI26 | |
| PFDAHVGKPTRRSDR | 611 | Q13796 | |
| NHISRIPPGVFSKLE | 181 | P51888 | |
| FPFPRIVVGATLHSK | 796 | Q9NQW1 | |
| EKRGLQRRATPHPSE | 466 | Q14160 | |
| PREPHTKAPRGFAFV | 46 | Q9BRL6 | |
| AQHNGSEPASPKRER | 321 | Q8N6T7 | |
| DTPFSKDRNGHVKRP | 326 | O94993 | |
| SERPLPRAALHSFKA | 911 | P36956 | |
| RHKTKGRLSRFEPPQ | 221 | O15042 | |
| QVHIPSLGFAKPDLR | 5091 | Q8IVF2 | |
| KKGTVAPHDQSPRRR | 6 | Q13733 | |
| EQKPTRHFLPIGDSS | 441 | Q96M02 | |
| NTFHILRPTKAPGFV | 2021 | A5YKK6 | |
| QKERETPPRFAQHGT | 471 | P23246 | |
| RIHVPKPLDRNDGTF | 86 | Q7Z4H8 | |
| HFKKVRGPSRADPNH | 361 | O75351 | |
| RASPAHSPRENGIDK | 261 | Q04724 | |
| KHLRVLPAAGPTAFS | 1176 | A4D1E1 | |
| ALHRGLIFNPRAKPS | 721 | Q12768 | |
| SHGQLKSVPQRTDFP | 116 | P17023 | |
| QRERALASLGKPLHP | 561 | Q9BQ52 | |
| IKAGPFHSERRPSQS | 1806 | O75970 | |
| LRLGFTSKDPSRIHP | 121 | O76050 | |
| HLAVNRVPRSGKPAE | 586 | P29401 | |
| RLHQEAPSNSGKPSR | 1176 | A0A1B0GUW6 | |
| HGAFPDAQLPSKRII | 631 | Q9Y5W7 | |
| CRHPTGGSFIRPNKV | 61 | Q15813 | |
| FHLGDRPIPVTFKRA | 186 | Q9H4I3 | |
| SSLRGFFPATVQPHK | 1021 | A6NE52 | |
| SVPHLPEKQATGRFE | 331 | Q96RF0 | |
| RPQSRGAHLFPEKLE | 696 | Q9NS62 | |
| AGPRPKARHQAETSQ | 66 | Q12815 | |
| HRSFPVRERTHPGGK | 151 | Q7L945 | |
| SPGSRLRTQEKAHPE | 66 | Q13077 | |
| KHPVIPQGTASLRFS | 881 | A0A0J9YWL9 | |
| FKRKPHTNGDAPSHR | 106 | Q8TC07 | |
| ESSPRPHRIAGVKRF | 46 | Q6ZVQ6 | |
| GREHAAQRLFPDKLP | 86 | P36402 | |
| KQVHRPLQTPDLSGF | 181 | P36402 | |
| ASPRARPKELRFHSI | 41 | Q53GA4 | |
| TSGDKPVSPHFVRRQ | 2186 | Q8IUG5 | |
| TTRSPRHPGVIFKAL | 386 | Q9HBF4 | |
| GSPTEKQRSLPASHR | 376 | Q96IT1 | |
| HPSFRTPQRDHTGEK | 176 | Q9UC07 | |
| IPQNDLLGHPKTRAF | 356 | P36537 | |
| EGHVKQVSPRRPQAT | 141 | Q8WTV1 | |
| SLHSIAQNKGIRPFP | 116 | P52735 | |
| VGFFHTAPPTGRRRK | 1971 | Q9Y3S1 | |
| DRIKGSLLPRPGHNF | 96 | Q9BWQ6 | |
| KERNLTLRPAGPEHS | 181 | Q13308 | |
| GSPFREPLIKFLTRH | 1551 | Q9Y4A5 | |
| HQRGERDTAIPQPAK | 1361 | Q702N8 | |
| RKSPSERHVLGQPSR | 1211 | P15822 | |
| HTRGVPPLLKSFLQE | 411 | Q6P2D8 | |
| EQPSHPEGSRRAKLE | 126 | Q8IV31 | |
| PGPSGFHKQRRSLDT | 431 | Q9ULE0 | |
| VFLDRKLGTQPSLPH | 121 | Q8TEY7 | |
| RQTPRHAAPGKDTDR | 2511 | O75962 | |
| PGSHVRQKAVRRPSS | 441 | O75382 | |
| KGTFVLRDLPLQHSP | 606 | Q03721 |